Osaic Holdings
ADPT icon

Osaic Holdings’s Adaptive Biotechnologies ADPT Stock Holding History

Osaic Holdings’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
136,331
+337
+0.2% +$5.16K ﹤0.01% 1984
2026
Q1 		$1.89M Buy
135,994
+11,676
+9% +$186K ﹤0.01% 2128
2025
Q4 		$2.02M Buy
124,318
+9,898
+9% +$162K ﹤0.01% 2085
2025
Q3 		$1.51M Buy
114,420
+18,927
+20% +$231K ﹤0.01% 2420
2025
Q2 		$1.11M Buy
95,493
+25,579
+37% +$232K ﹤0.01% 2422
2025
Q1 		$519K Buy
69,914
+9,924
+17% +$76.3K ﹤0.01% 2838
2024
Q4 		$360K Buy
59,990
+2,537
+4% +$14K ﹤0.01% 3095
2024
Q3 		$294K Buy
57,453
+450
+0.8% +$1.96K ﹤0.01% 3329
2024
Q2 		$206K Buy
57,003
+2,512
+5% +$7.97K ﹤0.01% 3533
2024
Q1 		$175K Sell
54,491
-1,314
-2% -$5.08K ﹤0.01% 3799
2023
Q4 		$273K Sell
55,805
-56,642
-50% -$258K ﹤0.01% 3678
2023
Q3 		$613K Buy
112,447
+94,105
+513% +$622K ﹤0.01% 3073
2023
Q2 		$123K Sell
18,342
-33,412
-65% -$248K ﹤0.01% 4273
2023
Q1 		$457K Buy
51,754
+2,976
+6% +$26.2K ﹤0.01% 3173
2022
Q4 		$374K Sell
48,778
-2,448
-5% -$19K ﹤0.01% 3294
2022
Q3 		$365K Sell
51,226
-3,912
-7% -$36.8K ﹤0.01% 3196
2022
Q2 		$446K Buy
55,138
+4,671
+9% +$41.1K ﹤0.01% 3044
2022
Q1 		$699K Sell
50,467
-2,826
-5% -$44.4K ﹤0.01% 2897
2021
Q4 		$1.5M Buy
53,293
+992
+2% +$30.4K ﹤0.01% 2033
2021
Q3 		$1.78M Sell
52,301
-36
-0.1% -$1.3K ﹤0.01% 1823
2021
Q2 		$2.14M Buy
52,337
+7,003
+15% +$272K ﹤0.01% 1647
2021
Q1 		$1.83M Buy
45,334
+2,726
+6% +$148K ﹤0.01% 1701
2020
Q4 		$2.52M Sell
42,608
-8,507
-17% -$439K 0.01% 1272
2020
Q3 		$2.48M Buy
51,115
+2,445
+5% +$103K 0.01% 1179
2020
Q2 		$2.35M Sell
48,670
-135,110
-74% -$4.93M 0.01% 1159
2020
Q1 		$5.11M Buy
+183,780
New +$5.13M 0.02% 596

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Osaic Holdings's ADPT Position: Q2 2026 in Review

Osaic Holdings increased its Adaptive Biotechnologies (ADPT) stake by 0.25% in Q2 2026, buying an estimated $5.16K and bringing the position to 136,331 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Osaic Holdings first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.11M in Q1 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Osaic Holdings held 136,331 shares of Adaptive Biotechnologies worth $2.92M as of Q2 2026.
  • Osaic Holdings bought 337 Adaptive Biotechnologies shares in Q2 2026, an estimated $5.16K.
  • Adaptive Biotechnologies made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #1984 holding.
  • Osaic Holdings first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Adaptive Biotechnologies position peaked at $5.11M in Q1 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.